In vitro studies confirmed the inhibition of pro-inflammatory target genes, including CXC chemokines and IFN/STAT1 signature in monocyte-derived MP from RA synovial fluid [102]. The gene discussed is IFNA1; the disease is rheumatoid arthritis.